NSCLC
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Diagnosed as non-small cell lung cancer by pathology and/or histology; 2. Clinical stage:?B or ?;central or partial peripheral lung cancer whose main lesion in lung =5 cm; 3. There is a clear measurable lesions in lung and total single diameter of lesions in lung =50mm; 4. Case of initial treatment; 5. ECOG:0-1;Expected survival period =3 months; 6. Aged 18-75 years; Without other serious illness of heart,lung,liver,kiney or blood system; 7. Agreed to participate in this study and signed informed consent.
Exclusion criteria
Exclusion criteria: 1. Patients who need radiotherapy for symptomatic brain metastases or bone metastases; 2. Patients who are receiving or are prepared to receive targeted drug therapy; 3. pregnant women and lactating women, or patient who has other serious disease of heart, lung, liver, kidney, blood system, or the researchers believe one is unsuitable for the group; 4. allergy to the drugs; 5. patients undergoing other drug trials.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| RR; | — |
Secondary
| Measure | Time frame |
|---|---|
| PFS;QOL;tumor markers; | — |
Countries
China
Contacts
Beijing Hospital of TCM